ReviewAntibiotics (Basel, Switzerland)2026
Urinary Tract Infections: Etiology and Emerging Therapeutic Approaches.
Review in Antibiotics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Urinary tract infections (UTIs) are considered a significant public health issue due to their high incidence and prevalence, most notably among women. The potential for complications, including recurrent infections and antibiotic resistance, negatively impacts patient quality of life and correspondingly results in elevated healthcare costs. Efficacy of antibiotic pharmacotherapy has been shown to be limited in the treatment of UTIs. The use of antibiotics has been further exacerbated by the unprecedented spread of antimicrobial-resistant organisms. This paper reviews the microbiome specific to UTIs and the formation of biofilms in UTI patients, and presents the current status of novel biological and chemical approaches designed to inhibit and eradicate biofilms in UTI patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.